Where does Mati Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Mati Therapeutics, Inc. ranks #9,817 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Mati Therapeutics, Inc. hold?

Mati Therapeutics, Inc. holds 32 US utility patents granted between 2015 and 2025, spanning 8 technology areas.

What is Mati Therapeutics, Inc.'s Innovation Score?

Mati Therapeutics, Inc. has an Innovation Score of 38.6 out of 100 (top 40% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Mati Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Mati Therapeutics, Inc.'s recent grant velocity is -45% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Mati Therapeutics, Inc.'s patents?

Mati Therapeutics, Inc.'s patents average 20.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Mati Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Mati Therapeutics, Inc.

Q: What technology areas does Mati Therapeutics, Inc. focus on?

Mati Therapeutics, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 32 patents, ranking #197 of 3,082 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 32 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Mati ranks #9,817 of 49,997 tracked US assignees by granted-patent volume, with 32 patents across 8 technology areas.

#9,817
of 49,997 US assignees by volume: Top 40%
by Innovation Score (38.6/100): 20.1
avg claims per patent: -45%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9817 · US Corporation #9,817 · 32 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 32 grants
UPPER-Q #9,817/49,997
PHOTO-FINISH Maricap Oy
CPC-NARROW A61F · 8 areas
INNOV-THIN 38.6/100
CLAIMS-DENSE 20.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -45% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Maricap Oy (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Mati’s 38.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.1 pts (31%) Velocity 4.4 pts (11%) Breadth 10.0 pts (26%) Claim depth 12.1 pts (31%)

Qualcomm Incorporated · highest

85
IronRidge · near

39
Mati Therapeutics · this assignee

39
Maxlinear Asia… · near

39
Medtronic Monitoring · near

39
Nexrf · near

39
3D Lighting… · lowest

7

What this shows Mati's Innovation Score is 38.6/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Mati?

Each dot is one of Mati’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Mati’s own 20.1 claims/patent is ABOVE the 14.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Mati vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Mati's grants concentrate

Mati Therapeutics, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2017 (7 grants) versus a trough of 1 in 2021. By volume, Mati sits between Mips AB and MiniPumps LLC.

Mati's three-year grant acceleration

Mati Therapeutics, Inc. shows 6 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Mips AB

32
Mitsubishi Heavy…

32
Mitsubishi Jidosh…

32
Maricap Oy

32
Mccue

32
Meta

32
Midrex

32
Minipumps

32
Mati Therapeutics ◀

32

What this shows Mati holds 32 patents at rank #9,821, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Mati

By rank, the assignees closest to #9,821 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Mati's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Mati, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Mati ranks #197 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Nexrf Corp. 39 IronRidge, Inc. 39 Medtronic Monitoring, Inc. 39 Maxlinear Asia Singapore PTE Ltd 39

Mati's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Mati Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	15.6%
2016	2	6.3%
2017	7	21.9%
2018	2	6.3%
2019	4	12.5%
2020	4	12.5%
2021	1	3.1%
2022	3	9.4%
2023	2	6.3%
2024	1	3.1%
2025partial year	1	3.1%

Which technologies does Mati Therapeutics, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 32

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 21

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 16

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 13

Y10T - Technical Subjects Covered BY Former US Classification 4

A61B - DIAGNOSIS; SURGERY; Identification 3

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Mati Therapeutics, Inc.'s patent record in context - here's where to go next.

Mati Therapeutics, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #9,817 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Mati Therapeutics, Inc. against Mips AB, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.